ArticleWorld journal of microbiology & biotechnology2026
In vitro antibacterial effects and mechanism of action of six constituents of Litsea cubeba essential oil against Helicobacter pylori.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Litsea cubeba essential oil (EO) has been previously proven to possess a potent anti-Helicobacter pylori (H. pylori) activity. The current study investigated antibacterial activity of six single compounds present in the EO and their mechanisms of action against the stomach pathogen. The results demonstrated that citronellol displayed the most potent anti-H. pylori activity with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 0.04 and 0.16 mg/mL, followed by citral with MIC and MBC of 0.08 and 0.31 mg/mL, respectively. Notably, all tested compounds exerted bactericidal effects at 24 h, except for limonene and 1,8-cineole at 36 h of treatments. Citral and citronellol effectively inhibited 88.09 and 71.69% of biofilm formation at ¾⋅MIC. Citral and citronellal exhibited excellent inhibitory activity against the bacterial urease with IC50 values of 0.145 and 0.332 mg/mL, respectively. Citral, citronellol, and limonene at MBCs significantly increased membrane permeability of H. pylori with respective crystal violet uptake of 80.10%, 80.80%, and 85.57% but less pronounced than that of the EO (93.25%). Citronellal, citronellol, and limonene at MBC induced remarkable protein leakage in the bacterial cells (13.51, 15.96, and 14.36 µg/mL, respectively). SEM images revealed that citronellol and the EO at MBC had significant effects on the cell shape and disrupted the outer membrane. Especially, the H. pylori treatment with citronellol and the EO also caused extensive DNA fragmentation leading to the cell death. These findings highlighted the role of citral, citronellal, citronellol, and limonene as promising candidates for further development as anti-H. pylori agents.
Indexed as
Identifiers
42045701What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.